Pharming Group NV (PHAR)

0.975
-0.015(-1.51%)
  • Volume:
    3,432,259
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    0.971 - 0.997

PHAR Overview

Prev. Close
0.99
Day's Range
0.971-0.997
Revenue
172.44M
Open
0.993
52 wk Range
0.85-1.5
EPS
0.05
Volume
3,432,259
Market Cap
625.26M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
4,701,905
P/E Ratio
20.06
Beta
1.65
1-Year Change
-21.8%
Shares Outstanding
641,290,014
Next Earnings Date
Aug 05, 2021
What is your sentiment on Pharming Group NV?
or
Market is currently closed. Voting is open during market hours.

Pharming Group NV Analysis

  • Barclays CEO Resigns
    • ByTrade The News-

    Ireland Set To Sell Bills In Return For Markets Since Entering Bailout ConditionsEconomic Data(EU) ECB: €303M borrowed in overnight loan facility (lowest level since late...

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Sell
SummaryNeutralStrong SellStrong SellStrong SellStrong Sell

Pharming Group NV Company Profile

Pharming Group NV Company Profile

Employees
262

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Read More
  • Oh dear....not the best Q2 results, but expected. Diluted EPS hasn't changed. Outlook is OK I think.
    0
    • financial results tomorrow 💪
      0
      • I’m sorry to say but this Dutch company is probably the worst stock in Holland, where it fell from 227 € to only twenty cents.
        2
        • America is waking up! Pharming is the best Healtcare / Biothechnology stock to buy in 2021! The future of this company is very good. It's up to you! Cheers to day!
          1
          • Here we go
            0
            • patent pending in the US. NICE 1
              0
              • what happen to their COVID vaccine?
                0
                • never had a vaccin. ruconest cured people after theyhad complications due to covid
                  0
                • A dead bird. Waiting 4 martch before closing the door for ever.
                  0
                • 0
              • ipo boring stock
                0
                • Today at 9:00 am NL time , pharming buy buy buy ...... At the AEX index
                  0
                  • Maybe a other day
                    0
                  • tomorrow when it is red
                    0
                • part 3 Thesis 10: Did Pharming have butter on its head not to publish this Thesis 11: Is the AFM not expert enough to enforce the rules of the game, since the necessary expertise is required to make sense of the trial data. Thesis 12: Would it not help to give the AFM a hand on the way, by providing insight into what might be the purport of the trial in the context of the AFM's duty to report on press releases. Salut
                  1
                  • part 2 Thesis 4: The company that this FDA approval is given to is the company that directly owns or licenses this drug. In this case, it is Pharming. Theorem 5: So this would mean, that Imu.... would only be allowed to start a phase 4 study with Ruconest after Pharming has received FDA approval to use Ruconest for phase 3 post Covid. Statement 6: There is no question of a period of silence from Pharming. Has also been discussed several times etc. And also confirmed by investor relations of Pharming. Because Nasdaq listing is not an IPO, but a simple listing where no additional shares have been issued. Statement 7: The market for post Covid is probably a multiple of HAE, given that the USA has over 10 mio Covid infections. Thesis 8: The only commercial product (combo product + drug) Pharming has is Ruconest against HAE. . Thesis 9: With that comes a very large application opportunity.
                    1
                    • I found this and translated to English. part 1 The passenger wrote on 17 January 2021 20:02: Hi, I am trying to make 1 more attempt to clarify my position. Just a few statements / facts in a row according to yours truly, a layman in this field, but eager to learn, and have already read quite a bit, to give an insight into my limited, not omniscient perception. Thesis 1: It should not matter who leads or initiates this research. Any commercial company with certain licenses may initiate research, provided permission is obtained. Thesis 2: In order to get approval to start a trial of a drug in phase 4,, however, approval must first have been granted to use this drug in phase 3. Thesis 3: The drug in question is Ruconest. There are several trials running here. I have not yet seen any approval from the FDA to use Ruconest for phase 3 against post Covid. Translated with www.DeepL.com/Translator (free version)
                      1
                      • What's happening?
                        0
                        • Any covid news?
                          0
                          • it is DEAD and BURIED
                            0
                        • Still waiting Americans wake up and buy this opportunity at ML term ;-)
                          0
                          • Spot onA bargain
                            0
                        • Golden cross incoming!
                          0
                          • :atest on the IPO approval - https://sec.report/Document/0001354457-20-000824/ as Certification by an exchange approving securities for listing. Fingers crossed on the IPO tomorrow :)
                            0
                            • looks like the US IPO is moved to tomorrow according to SEC - https://sec.report/Document/0001193125-20-324278/
                              0
                              • https://seekingalpha.com/article/4395655-pharming-group-lines-up-u-s-offering-plan - "As to valuation, the firm’s enterprise value will likely exceed $1 billion after a successful offering".
                                0
                                • https://www.biopharmcatalyst.com/calendars/ipo-calendar  - December 2020 Biotech IPOs are all up from 26% to 251% as of December 20th. Let's see what's in store for Pharming 🤞
                                  0
                                  • https://moneyandmarkets.com/paychex-earnings-forecast  "The Renaissance IPO ETF (NYSE: IPO) — an exchange-traded fund that tracks IPOs — is up 83.6% in 2020." happy trading!
                                    0
                                    • Good to know that Goldman Sachs is a main shareholder for Pharming.
                                      0
                                      • What do you think, positiive or negative?
                                        0
                                      • robbe van hoof positive. They usually put a price target for stocks which bumps up the price - i.e.  https://finance.yahoo.com/news/tesla-gets-goldman-sachs-upgrade-031445147.html
                                        0
                                      • Global InvestorTurkmendinmi Sen ?
                                        0
                                    • On Nasdaq the ipo price is also $12,10.
                                      0
                                      • Indees, very strange imo
                                        0
                                      • Indeed*
                                        0
                                      • Nevermind: 10/1
                                        0
                                    • The IPO price of Pharming Group on NASDAQ is 12.10, what does this mean for the stock price of Pharming Group NV?
                                      0
                                      • on nasdaq.com there is a price listed $ 1,405.stop daydrinking
                                        0
                                      • Jesse De Vroede I was referring to the IPO price mentioned on investing.com, stop dayjudging
                                        0
                                      • robbe van hoofooooeh touché
                                        0
                                    • Pharming goes the US of A, I will keep this stock for a while
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.